June 24, 2022
Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago.
ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV. and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction. Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
June 24, 2022
In this podcast Liv Swonger, a P4 student at Idaho State University College of Pharmacy, and Dr. Daniel Cobaugh will discuss Liv’s experiences as LGBTQ person and the intersection with her career path.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
June 23, 2022
Please join us for an introduction to pharmacists career ladders, including their impact and benefits. This session will outline a pharmacist career ladder while providing insight into barriers and strategies for success with implementation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
June 22, 2022
This podcast will feature mentor-mentee pairs that participated in the inaugural cohort of the ASHP Guided Mentorship Program. Mentors and mentees will share insights of their experience with the program, reasons for pursuing a professional mentoring relationship, and tips for candidates considering the program.
June 19, 2022
This podcast is an offering from the Black women on ASHP’s staff to the Black women in ASHP’s membership. Featuring strategies sourced from several Black ASHP staff members, the discussion centers on joy as an active form of well-being among Black women. It is a love letter that encourages members to be intentional about choosing joy and nurturing it as a daily practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
June 18, 2022
Harms from opioid misuse continue despite significant attention to this public health crisis. Symptoms of acute opioid withdrawal are incredibly disabling and a leading driver in returning to use. Numerous methods exist to palliate withdrawal symptoms and improve the likelihood a patient who uses opioids may achieve long term recovery.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
June 17, 2022
This podcast episode is an interview with five speakers recognized in 2021 as ASHP Fellows (FASHP). Fellows provide advice and encouragement for new practitioners in their career transitions, including recommendations on staying up to date with practice changes, professional involvement, and other timely topics such as burnout and resilience.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
June 16, 2022
The field of nanomedicine is a complex and rapidly growing scientific domain. Nanomedicine encompasses a large and diverse number of pharmaceutical formulations including liposomes, micelles, nanoparticles and polymer-drug conjugates. Pharmacists will be provided with a view of the landscape of nanomedicines, critical research gaps and implications for patient-safety and therapeutic efficacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
June 15, 2022
In this podcast Dean James Scott of Touro University California College of Pharmacy and Dr. Daniel Cobaugh will share Dean’s Scott’s life experiences and his academic leadership journey as a gay man.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
June 14, 2022
For a school of pharmacy, developing a cohesive PGY-1 residency program can be challenging when faculty work across a large number of different health systems. With the growing demand of post-graduate training opportunities, what can these institutions do to help meet that demand? In this episode of Educator Essentials, we talk about some innovative approaches in creating a PGY-1 residency experience utilizing multiple learning sites.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.